Journal of Contemporary Brachytherapy (Oct 2021)

Brachytherapy for oligometastatic prostate cancer to the penis

  • Nicolas Martz,
  • Nicolas Benziane-Ouaritini,
  • Mathieu Gautier,
  • Isabelle Brenot-Rossi,
  • Lucile Montagne,
  • Naji Salem,
  • Yohan Bodokh,
  • Jean-Michel Hannoun-Levi

DOI
https://doi.org/10.5114/jcb.2021.109754
Journal volume & issue
Vol. 13, no. 5
pp. 593 – 597

Abstract

Read online

The origin of penile metastases is in 70% of cases from primary pelvic cancers (genitourinary and recto-sigmoid primary tumors). The prognosis is poor and it is often associated with synchronous bone metastases at the time of diagnosis. We present the case of a 61-year-old patient who developed a penile induration 7 years after radical prostatectomy followed by adjuvant external beam radiation therapy for high-risk prostatic adenocarcinoma. Biopsies confirmed the metastatic localization and a detailed assessment failed to find any further remote lesions. Faced with this penile oligometastatic prostate cancer, we proposed an ablative treatment based on interstitial multi-catheter high-dose rate brachytherapy. At the six-month follow-up, clinical examination and 68Ga-PSMA-11-PET confirmed a complete response of the penile tumor without new lesion at a distance.

Keywords